Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama 641-8510, Japan.
Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama 641-8510, Japan.
Atherosclerosis. 2014 Apr;233(2):697-703. doi: 10.1016/j.atherosclerosis.2013.12.052. Epub 2014 Jan 28.
Although monocytes appear to be actively involved in the onset of acute coronary syndrome (ACS), they are heterogenous in human peripheral blood. How up-regulation of monocyte subsets leads to coronary plaque rupture followed by thrombus formation remains unclear. Recent studies have shown that P-selectin glycoprotein ligand-1 (PSGL-1) is involved in monocyte activation in patients with thrombus formation. We therefore investigated the relationship between the expression of PSGL-1 on monocyte subsets and thrombus formation using frequency-domain optical coherence tomography (FD-OCT) in patients with ACS.
We enrolled a total of 100 individuals in this study: patients with acute myocardial infarction (AMI, n=25), unstable angina pectoris (UAP, n=20), or stable angina pectoris (n=35) who underwent coronary angiography, and control subjects (n=20). Three monocyte subsets (CD14++CD16-, CD14++CD16+, and CD14+CD16+) and the expression of PSGL-1 were measured by flow cytometry. In patients with AMI and UAP, FD-OCT was performed before percutaneous coronary intervention.
Circulating peripheral CD14++CD16+ monocytes expressed PSGL-1 more frequently than CD14++CD16- and CD14+CD16+ monocytes in patients with ACS. The expression of PSGL-1 on circulating peripheral CD14++CD16+ monocytes was significantly elevated in patients with AMI compared with the other 3 groups. Moreover, the expression levels of PSGL-1 on CD14++CD16+ monocytes were significantly higher in patients with plaque rupture or intracoronary thrombus assessed by FD-OCT.
Up-regulation of PSGL-1 on CD14++CD16+ monocytes may be a crucial role in plaque rupture and thrombus formation.
虽然单核细胞似乎积极参与急性冠状动脉综合征(ACS)的发病,但它们在人外周血中是异质的。单核细胞亚群的上调如何导致斑块破裂,随后形成血栓仍不清楚。最近的研究表明,P 选择素糖蛋白配体-1(PSGL-1)参与血栓形成患者的单核细胞激活。因此,我们使用频域光相干断层扫描(FD-OCT)研究了 ACS 患者中单核细胞亚群上 PSGL-1 的表达与血栓形成之间的关系。
我们共纳入 100 名患者:急性心肌梗死(AMI,n=25)、不稳定型心绞痛(UAP,n=20)或稳定型心绞痛(n=35)患者行冠状动脉造影,对照组(n=20)。通过流式细胞术测量三种单核细胞亚群(CD14++CD16-、CD14++CD16+和 CD14+CD16+)和 PSGL-1 的表达。在 AMI 和 UAP 患者中,在经皮冠状动脉介入治疗前进行 FD-OCT。
ACS 患者外周血循环 CD14++CD16+单核细胞表达 PSGL-1 的频率高于 CD14++CD16-和 CD14+CD16+单核细胞。与其他 3 组相比,AMI 患者外周血循环 CD14++CD16+单核细胞上 PSGL-1 的表达显著升高。此外,FD-OCT 评估的斑块破裂或冠状动脉内血栓形成患者 CD14++CD16+单核细胞上 PSGL-1 的表达水平显著升高。
CD14++CD16+单核细胞上 PSGL-1 的上调可能在斑块破裂和血栓形成中起关键作用。